{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:55:44Z","timestamp":1795035344453,"version":"4.10.2"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178059","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T15:33:04Z","timestamp":1495726384000},"page":"e0178059","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Low rates of antibiotic resistance and infectious mortality in a cohort of high-risk hematology patients: A single center, retrospective analysis of blood stream infection"],"prefix":"10.1371","volume":"12","author":[{"given":"Jason R.","family":"Conn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Catchpoole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Runnegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally J.","family":"Mapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7064-2362","authenticated-orcid":true,"given":"Kate A.","family":"Markey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMct1210890","article-title":"Colony-stimulating factors for febrile neutropenia during cancer therapy","volume":"368","author":"CL Bennett","year":"2013","journal-title":"The New England journal of medicine"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ajh.23661","article-title":"Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes","volume":"89","author":"SA Buckley","year":"2014","journal-title":"Am J Hematol"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4103\/0019-509X.175330","article-title":"Clinical and microbiological profile of febrile neutropenia in solid tumors and hematological malignancies at a tertiary cancer care center in South India","volume":"51","author":"LA Jacob","year":"2014","journal-title":"Indian journal of cancer"},{"key":"ref4","first-page":"596504","article-title":"Clinical and Microbiological Profile of Pathogens in Febrile Neutropenia in Hematological Malignancies: A Single Center Prospective Analysis","volume":"2015","author":"M Taj","year":"2015","journal-title":"Journal of oncology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"986938","DOI":"10.1155\/2014\/986938","article-title":"Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update","volume":"2014","author":"P Villafuerte-Gutierrez","year":"2014","journal-title":"Advances in hematology"},{"issue":"Suppl 1","key":"ref6","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/383050","article-title":"Management of fever in neutropenic patients with different risks of complications","volume":"39","author":"J Klastersky","year":"2004","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","article-title":"Survival in neutropenic patients with severe sepsis or septic shock","volume":"40","author":"M Legrand","year":"2012","journal-title":"Critical care medicine"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cncr.20983","article-title":"Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy","volume":"103","author":"V Caggiano","year":"2005","journal-title":"Cancer"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.02561-14","article-title":"Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia","volume":"58","author":"RG Rosa","year":"2014","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/QCO.0000000000000038","article-title":"Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact","volume":"27","author":"EM Trecarichi","year":"2014","journal-title":"Current opinion in infectious diseases"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bcp.12310","article-title":"The prevention and management of infections due to multidrug resistant organisms in haematology patients","volume":"79","author":"JA Trubiano","year":"2015","journal-title":"British journal of clinical pharmacology"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"Cr304","DOI":"10.12659\/MSM.881773","article-title":"Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients","volume":"17","author":"ES Horasan","year":"2011","journal-title":"Medical science monitor: international medical journal of experimental and clinical research"},{"key":"ref13","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement. CLSI document M100-S21 Wayne, PA.2011."},{"key":"ref14","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, Version 4.0 <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.eucast.org\" xlink:type=\"simple\">http:\/\/www.eucast.org<\/ext-link> 2014."},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.bmt.1701201","article-title":"Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants","volume":"21","author":"R Koya","year":"1998","journal-title":"Bone marrow transplantation"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1155\/2014\/702621","article-title":"Mortality related to coagulase-negative staphylococcal bacteremia in febrile neutropenia: A cohort study","volume":"25","author":"RG Rosa","year":"2014","journal-title":"The Canadian journal of infectious diseases & medical microbiology"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2012-02-410746","article-title":"All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)","volume":"120","author":"HJ Iland","year":"2012","journal-title":"Blood"},{"issue":"6b","key":"ref18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1445-5994.2008.01724.x","article-title":"Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy","volume":"38","author":"CO Morrissey","year":"2008","journal-title":"Internal medicine journal"},{"key":"ref19","first-page":"414","article-title":"Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies","volume":"2013","author":"J Gea-Banacloche","year":"2013","journal-title":"Hematology \/ the Education Program of the American Society of Hematology American Society of Hematology Education Program"},{"key":"ref20","first-page":"CD007107","article-title":"Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy","volume":"12","author":"N Skoetz","year":"2015","journal-title":"The Cochrane database of systematic reviews"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jinf.2014.05.018","article-title":"Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours","volume":"69","author":"M Marin","year":"2014","journal-title":"The Journal of infection"},{"issue":"45","key":"ref22","doi-asserted-by":"crossref","first-page":"e1931","DOI":"10.1097\/MD.0000000000001931","article-title":"Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study","volume":"94","author":"L Wang","year":"2015","journal-title":"Medicine"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ajh.24489","article-title":"Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey","volume":"91","author":"EM Trecarichi","year":"2016","journal-title":"American journal of hematology"},{"key":"ref24","article-title":"Severe Sepsis and Septic Shock, eTG complete","year":"2016"},{"key":"ref25","unstructured":"Australian Commission on Safety and Quality in Health Care. Preliminary Report on Antimicrobial Use and Resistance in Australia (AURA). Sydney: 2014."},{"issue":"12 Pt 1","key":"ref26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"142","author":"A Gafter-Gvili","year":"2005","journal-title":"Annals of internal medicine"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"G Bucaneve","year":"2005","journal-title":"The New England journal of medicine"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.20411\/pai.v1i2.115","article-title":"Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant Recipients","volume":"1","author":"CG Hauck","year":"2016","journal-title":"Pathog Immun"},{"issue":"16","key":"ref29","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"J Klastersky","year":"2000","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00520-013-1758-y","article-title":"The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients","volume":"21","author":"J Klastersky","year":"2013","journal-title":"Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T11:43:25Z","timestamp":1540035805000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178059"}},"subtitle":[],"editor":[{"given":"Halvard","family":"B\u00f6nig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,19]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178059","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0178059.g001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0178059.g002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0178059.t001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0178059.t002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0178059.t003","asserted-by":"subject"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,19]]}}}